Segui
Nicola Fusco, M.D.
Nicola Fusco, M.D.
European Institute of Oncology (IEO), University of Milan, Italy
Email verificata su unimi.it
Titolo
Citata da
Citata da
Anno
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
2172014
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
1472016
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast
S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ...
Histopathology 67 (5), 719-729, 2015
1002015
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer
G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ...
BioMed research international 2014, 2014
932014
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ...
Genes 11 (7), 719, 2020
912020
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ...
Modern Pathology 29 (11), 1292-1305, 2016
842016
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
N Fusco, U Malapelle, M Fassan, C Marchiò, S Buglioni, S Zupo, ...
Frontiers in Oncology 11, 644737, 2021
802021
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYBNFIB fusion gene
J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ...
The Journal of pathology 244 (2), 143-150, 2018
802018
Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability
N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ...
JNCI Cancer Spectrum 2 (4), pky056, 2018
772018
Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management
A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ...
The Breast 44, 15-23, 2019
732019
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ...
Modern Pathology 26 (6), 816-824, 2013
732013
HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer
K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ...
Frontiers in molecular biosciences 9, 834651, 2022
722022
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study
E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ...
The Journal of pathology 237 (2), 166-178, 2015
602015
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ...
The Journal of pathology 238 (5), 677-688, 2016
592016
Targeting immune-related biological processes in solid tumors: we do need biomarkers
F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ...
International journal of molecular sciences 20 (21), 5452, 2019
562019
Impact of rehabilitation on breast cancer related fatigue: a pilot study
M Invernizzi, A De Sire, L Lippi, K Venetis, E Sajjadi, F Gimigliano, ...
Frontiers in Oncology 10, 556718, 2020
542020
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study
A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi
Aging clinical and experimental research 32, 959-962, 2020
532020
The role of the pathologist in the next-generation era of tumor molecular characterization
V Angerilli, F Galuppini, F Pagni, N Fusco, U Malapelle, M Fassan
Diagnostics 11 (2), 339, 2021
512021
HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
N Fusco, S Bosari
World Journal of Gastroenterology 22 (35), 7926, 2016
472016
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: Which are the main risk factors? A retrospective case-control study
A De Sire, L Losco, C Cisari, A Gennari, R Boldorini, N Fusco, E Cigna, ...
European review for medical and pharmacological sciences 24 (15), 8028-8035, 2020
452020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20